We are live on ! Find out more
BRA

Bender Robert & Associates Portfolio holdings

AUM $417M
1-Year Est. Return 25.02%
This Fund
S&P 500
This Quarter Est. Return
+3.04%
1 Year Est. Return
+25.02%
3 Year Est. Return
+98.12%
5 Year Est. Return
+139.29%
10 Year Est. Return
+812.75%
AUM
$168M
AUM Growth
-$3.01M
Cap. Flow
-$7.02M
Cap. Flow %
-4.17%
Top 10 Hldgs %
59.32%
Holding
59
New
3
Increased
23
Reduced
23
Closed
4

Top Sells

Rank Stock Value
1
PCYC
PHARMACYCLICS INC
PCYC
+$7.11M
2
SBUX icon
Starbucks
SBUX
+$4.15M
3
NDLS icon
Noodles & Co
NDLS
+$1.18M
4
POWI icon
Power Integrations
POWI
+$1.17M
5
WOLF icon
Wolfspeed
WOLF
+$814K

Sector Composition

Rank Sector Weight
1 Healthcare 38.69%
2 Technology 23.8%
3 Consumer Discretionary 20.19%
4 Communication Services 8.85%
5 Industrials 2.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.95T
$20.4M 12.08%
648,988
-4,096
-0.6% -$131K
ILMN icon
2
Illumina
ILMN
$28.7B
$14.2M 8.44%
66,909
-963
-1% -$188K
GILD icon
3
Gilead Sciences
GILD
$162B
$12.6M 7.49%
107,793
-777
-0.7% -$84.9K
CELG
4
DELISTED
Celgene Corp
CELG
$11.4M 6.79%
98,838
-2,173
-2% -$248K
CTSH icon
5
Cognizant
CTSH
$22.3B
$8.32M 4.94%
136,184
-10,555
-7% -$663K
ISRG icon
6
Intuitive Surgical
ISRG
$128B
$7.62M 4.52%
141,462
-342
-0.2% -$19.1K
ALXN
7
DELISTED
Alexion Pharmaceuticals
ALXN
$6.67M 3.96%
36,909
+191
+0.5% +$33K
LULU icon
8
lululemon athletica
LULU
$13.4B
$6.62M 3.93%
101,416
-257
-0.3% -$16.7K
CAVM
9
DELISTED
Cavium, Inc.
CAVM
$6.21M 3.69%
90,288
-906
-1% -$63.5K
GOOG icon
10
Alphabet (Google) Class C
GOOG
$3.99T
$5.88M 3.49%
222,020
-21,948
-9% -$588K
META icon
11
Meta Platforms (Facebook)
META
$1.51T
$5.33M 3.16%
62,094
+21,009
+51% +$1.72M
ULTA icon
12
Ulta Beauty
ULTA
$20.7B
$5.18M 3.08%
33,555
-138
-0.4% -$21.2K
VIPS icon
13
Vipshop
VIPS
$7.08B
$5.05M 3%
226,990
-360
-0.2% -$9.54K
VMW
14
DELISTED
VMware, Inc
VMW
$4.87M 2.89%
56,805
-965
-2% -$84.2K
BIIB icon
15
Biogen
BIIB
$29.5B
$4.5M 2.67%
11,132
+86
+0.8% +$34.5K
ABBV icon
16
AbbVie
ABBV
$454B
$4.49M 2.66%
+66,810
New +$4.36M
SBUX icon
17
Starbucks
SBUX
$118B
$4.37M 2.59%
81,488
-81,792
-50% -$4.15M
AMZN icon
18
Amazon
AMZN
$2.49T
$4.2M 2.49%
193,500
-1,580
-0.8% -$33K
MELI icon
19
Mercado Libre
MELI
$92.3B
$3.45M 2.05%
24,355
+58
+0.2% +$8.21K
BKNG icon
20
Booking.com
BKNG
$145B
$3.33M 1.98%
72,300
+1,500
+2% +$71.6K
MDVN
21
DELISTED
MEDIVATION, INC.
MDVN
$3.18M 1.89%
55,684
+1,516
+3% +$93.5K
BIDU icon
22
Baidu
BIDU
$35.8B
$2.98M 1.77%
14,968
+122
+0.8% +$25K
PRLB icon
23
Protolabs
PRLB
$1.85B
$2.28M 1.35%
+33,803
New +$2.39M
KMI icon
24
Kinder Morgan
KMI
$70.6B
$2.25M 1.33%
58,568
+2,758
+5% +$115K
TFM
25
DELISTED
THE FRESH MARKET, INC COM STK
TFM
$1.57M 0.93%
48,825
-738
-1% -$25.8K

Similar funds

Bender Robert & Associates's Q2 2015 Portfolio in Review

As of Q2 2015, Bender Robert & Associates held 59 positions worth $168M, down 1.8% from $171M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Bender Robert & Associates withdrew a net $7.02M in Q2 2015, closing 4 positions and reducing 23 holdings. Its most notable exit was PHARMACYCLICS INC, an estimated $7.11M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 33% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Bender Robert & Associates opened a new position in AbbVie worth $4.49M.

  • Bender Robert & Associates's largest Q2 2015 buy was AbbVie: 66,810 shares worth $4.49M.
  • Bender Robert & Associates added most to Meta Platforms (Facebook) in Q2 2015, an estimated $1.72M increase.
  • Bender Robert & Associates's biggest Q2 2015 reduction was Starbucks, cutting an estimated $4.15M.
  • Bender Robert & Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $7.11M.
  • Bender Robert & Associates's ten largest holdings make up 59% of its $168M portfolio in Q2 2015.
  • Bender Robert & Associates opened 3 new positions and closed 4 in Q2 2015.
  • Bender Robert & Associates's portfolio value fell 1.8% quarter-over-quarter to $168M.

Based on Bender Robert & Associates's 13F filing for Q2 2015, filed 10 Aug 2015.